BK-5-MAPBT
BK-5-MAPBT, also known as β-keto-5-MAPBT, is a possible entactogen of the benzothiophene and cathinone families.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
BK-5-MAPBT, also known as β-keto-5-MAPBT, is a possible entactogen of the benzothiophene and cathinone families. It is a potent monoamine releasing agent, including of serotonin and dopamine, and also acts as a potent serotonin 5-HT 1B receptor agonist. Conversely, norepinephrine release was not reported.
Unlike non-cathinone benzothiophenes like 5-MAPBT and 6-MAPBT, BK-5-MAPBT is very weak or inactive as a serotonin 5-HT 2B receptor antagonist and monoamine oxidase A (MAO-A) inhibitor. It produces anxiolytic-like and antiobsessional-like effects in the marble burying test in rodents. BK-5-MAPBT has been studied and patented by Matthew J. Baggott of Tactogen.
See also
Substituted benzothiophene Substituted cathinone 5-MAPBT BK-5-MAPB
Text derived from https://en.wikipedia.org/w/index.php?oldid=1320364734 under CC BY-SA 4.0; modifications have been made.